| 黄宴萍,许平,罗雨田,等.四种非传染性肝病的体检人员肝脏相关血清学标志物的调查分析[J].安徽医药,2023,27(12):2384-2388. |
| 四种非传染性肝病的体检人员肝脏相关血清学标志物的调查分析 |
| Analysis of liver-related serologic markers of four noninfectious liver diseases in the health examination population |
| |
| DOI：10.3969/j.issn.1009-6469.2023.12.011 |
| 中文关键词: 脂肪肝 肝囊肿 肝血管瘤 肝功能 血脂 诊断，鉴别 |
| 英文关键词: Fatty liver Hepatic cyst Hepatic hemangioma Liver function Blood lipids Diagnosis, differential |
| 基金项目:国家自然科学基金项目( 81973038) |
|
| 摘要点击次数: 963 |
| 全文下载次数: 541 |
| 中文摘要: |
| 目的探究体检人群中脂肪肝、肝囊肿、肝血管瘤、脂肪肝合并肝囊肿的肝脏相关血清学标志物。方法以深圳市萨米医疗中心 2018年 9月至 2020年 8月的体检人群为研究对象，根据肝胆 B超检查结果，肝病可分为单一肝病和肝病合并症，因而分为对照组和 4个非传染性肝病组，采用 Mann-Whitney U检验，比较各组的肝功能和血脂指标。结果共纳入 8 938例体检(男性 n=4 986，女性 n=3 952)为研究对象。男性中，脂肪肝组高密度脂蛋白胆固醇( HDLC)1.10(0.96，1.26)mmol/L低于对照组者1.33(1.14，1.53)mmol/L(P<0.05)，丙氨酸氨基转移酶( ALT)30.7(21.8，45.0)U/L、天门冬氨酸氨基转移酶( AST)22.0(18.3，27.6)U/L、总胆固醇 5.18(4.59，5.81)mmol/L、低密度脂蛋白胆固醇( LDLC)3.40(2.85，3.98)mmol/L高于对照组［ 19.0(14.1，26.3) U/L、19.0(16.4，22.3)U/L、4.81(4.28，5.38)mmol/L、3.11(2.62，3.65)mmol/L］(P<0.05)；脂肪肝合并肝囊肿组 ALT 24.0(18.0，35.0)U/L、AST 21.0(18.0，26.0)U/L、HDLC 1.00(1.00，1.00)mmol/L低于脂肪肝组［ 30.7(21.8，45.0)U/L、22.0(18.3，27.6)U/L、1.10(0.96，1.26)mmol/L］(P<0.05)； HDLC 1.00(1.00，1.00)mmol/L低于肝囊肿组 1.31(1.13，1.52)mmol/L(P<0.05)ALT 24.0(18.0，35.0)U/L、AST 21.0(18.0，26.0)U/L、总胆固醇 5.00(5.00，6.00)mmol/L高于肝囊肿组［ 18.5(14.8，24.0)U/L、19.6.6，22.3)U/L、2(1，4.88(4.29，5.63)mmol/L］(P<0.05)。女性中，脂肪肝组 HDLC 1.31(1.14，1.48)mmol/L低于对照组 1.61(1.41，1.83)mmol/L(P<0.05)，ALT 17.5(13.1，24.8)U/L、AST 17.9(15.2，22.4)U/L、总胆固醇 5.10(4.52，5.76)mmol/L、LDLC 3.36(2.74，3.93)mmol/L高于对照组［ 11.3(9.0，14.9)U/L、16.2(14.2，18.7)U/L、4.52(4.05，5.05)mmol/L、2.70(2.28，3.18)mmol/L］(P<0.05)；肝囊肿组总胆固醇 4.77(4.28，5.40)mmol/L、LDLC 2.88(2.48，3.38)mmol/L高于对照组［ 4.52(4.05，5.05)mmol/L、2.70(2.28，3.18)mmol/L］(P<0.05)；肝血管瘤组肝功能和血脂指标与对照组的均差异无统计学意义( P>0.05)；脂肪肝合并肝囊肿组 HDLC 1.00(1.00，1.00)mmol/L低于脂肪肝组 1.31(1.14，1.48)mmol/L和肝囊肿组 1.61(1.39，1.84)mmol/L(P<0.05)； ALT 18.0(14.0，28.0)U/L、AST 20.0(16.0，22.0)U/L高于肝囊肿组［ 11.6(9.2，15.7)U/L、16.4(14.2，19.4)U/L］(P<0.05)。结论肝功能和血脂指标是诊断和监测脂肪肝以及脂肪肝合并肝囊肿的理想指标，但在单纯的肝囊肿或肝血管瘤中的意义较为有限。 |
| 英文摘要: |
| Objective To explore liver-related serologic markers of fatty liver, hepatic cysts, hepatic hemangioma, and fatty livercombined with hepatic cysts in a health examination population.Methods The health examination population of Shenzhen Samii Med.ical Center from September 2018 to August 2020 was used as the study population. According to the results of hepatobiliary B-ultra. sound, liver disease can be divided into single liver disease and liver disease complications and thus divided into a control group andfour noninfectious liver disease groups, and the Mann-Whitney U test was used to compare the liver function and lipid indices of each group.Results A total of 8 938 subjects included (male n= 4 986 and female n =3 952) with health examination were included in the study. In males, high-density lipoprotein cholesterol (HDLC) of 1.10 (0.96, 1.26) mmol/L in the fatty liver group was lower than that ofthe control group of 1.33 (1.14, 1.53) mmol/L (P<0.05), and alanine aminotransferase (ALT) of 30.7 (21.8, 45.0) U/L, aspartate amino.transferase (AST) of 22.0 (18.3, 27.6) U/L, total cholesterol of 5.18 (4.59, 5.81) mmol/L, low density lipoprotein cholesterol (LDLC) of 3.40 (2.85, 3.98) mmol/L in the fatty liver group were higher than those in the control group [19.0 (14.1, 26.3) U/L, 19.0 (16.4, 22.3) U/L, 4.81 (4.28, 5.38) mmol/L, 3.11 (2.62, 3.65) mmol/L] (P<0.05); ALT of 24.0 (18.0, 35.0) U/L, AST of 21.0 (18.0, 26.0) U/L and HDLCof 1.00 (1.00, 1.00) mmol/L of the fatty liver combined with hepatic cyst group were lower than those in the fatty liver group [30.7 (21.8,45.0) U/L, 22.0 (18.3, 27.6) U/L, 1.10 (0.96, 1.26) mmol/L] (P<0.05), and HDLC of 1.00 (1.00, 1.00) mmol/L was lower than that in the hepatic cyst group of 1.31 (1.13, 1.52) mmol/L (P<0.05), ALT of 24.0 (18.0, 35.0) U/L, AST of 21.0 (18.0, 26.0) U/L and total cholester.ol of 5.00 (5.00, 6.00) mmol/L were higher than those in the hepatic cyst group [18.5 (14.8, 24.0) U/L, 19.2 (16.6, 22.3) U/L and 4.88(4.29, 5.63) mmol/L] (P<0.05). In females, HDLC of 1.31 (1.14, 1.48) mmol/L in the fatty liver group was lower than that in the controlgroup of 1.61 (1.41, 1.83) mmol/L (P<0.05), and ALT of 17.5 (13.1, 24.8) U/L, AST of 17.9 (15.2, 22.4) U/L, total cholesterol of 5.10(4.52, 5.76) mmol/L, LDLC of 3.36 (2.74, 3.93) mmol/L in the fatty liver group were higher than those in the control group [11.3 (9.0,14.9) U/L, 16.2 (14.2, 18.7) U/L, 4.52 (4.05, 5.05) mmol/L, 2.70 (2.28, 3.18) mmol/L] (P<0.05); total cholesterol of 4.77 (4.28, 5.40)mmol/L and LDLC of 2.88 (2.48, 3.38) mmol/L in the hepatic cyst group were higher than those in the control group [4.52 (4.05, 5.05)and 2.70 (2.28, 3.18) mmol/L] (P<0.05). There was no statistically significant difference between the liver function and lipid indices inthe hepatic hemangioma group and control group (P>0.05); the HDLC of 1.00 (1.00, 1.00) mmol/L in the fatty liver combined with he.patic cyst group was lower than that of the fatty liver group [1.31 (1.14, 1.48) mmol/L] and that of the hepatic cyst group [1.61 (1.39,1.84) mmol/L](P<0.05); ALT of 18.0 (14.0, 28.0) U/L and AST of 20.0 (16.0, 22.0) U/L in the fatty liver combined with hepatic cystgroup were higher than those of the liver cyst group [11.6 (9.2, 15.7) U/L and 16.4 (14.2, 19.4) U/L] (P<0.05).Conclusion The liver function and lipid indices were ideal for the diagnosis and monitoring of fatty liver and fatty liver combined with hepatic cyst but are ofmore limited significance in simple hepatic cysts or hepatic hemangioma. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
